FDA Approval of Axatilimab (Phase 2 AGAVE-201) : Episode 1
Overview of Graft-Versus-Host Disease
Panelists give an overview of Graft-vs-host Disease and the modern landscape of treatment.
Related Content
Panelists give an overview of Graft-vs-host Disease and the modern landscape of treatment.
